ABSTRACT
Chronic obstructive pulmonary disease (COPD) is the fourth largest cause of worldwide mortality. Presence of comorbidities is registered in 96% of COPD patients. The most important of these are cardiovascular diseases (coronary artery disease, arterial hypertension, chronic heart failure), which contribute to COPD patients' mortality in every third case. COPD and cardiovascular diseases have common risk factors and pathogenesis mechanisms. Cardioselective beta-blockers reduce morbidity risk and frequency of COPD exacerbation, are effective and safe in treatment of COPD patients.
Subject(s)
Cardiovascular Diseases , Heart Failure , Pulmonary Disease, Chronic Obstructive , Adrenergic beta-Antagonists , Cardiovascular Diseases/epidemiology , Comorbidity , Humans , Pulmonary Disease, Chronic Obstructive/epidemiologyABSTRACT
Is this paper discuss problems of selection of anticoagulant therapy in elderly patients with atrial fibrillation, use of unreasonably low doses of anticoagulants, their risks and adherence to therapy is discussed in the paper.
